Global Immunofluorescence Assay market analysis 2024, Forecast To 2033
2 Feb, 2024
The immunofluorescence assay market has experienced robust growth, escalating from $3.18 billion in 2023 to $3.43 billion in 2024, showcasing a compound annual growth rate (CAGR) of 8.1%. This growth in the historic period is attributed to increased disease diagnosis, a rise in research and development, an increase in autoimmune diseases, increased cancer diagnostics, and a rise in virology research. Strong growth is expected to continue, reaching $4.9 billion in 2028, with a CAGR of 9.3%. The forecasted growth is linked to factors such as increasing personalized medicine, rising infectious disease surveillance, a rise in autoimmune disorders, an increase in point-of-care testing, and an increasing focus on global health preparedness. Major trends in the forecast period include the adoption of multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, and the integration of digital pathology.
Global Immunofluorescence Assay Market Key Driver
The immunofluorescence assay market is experiencing substantial growth propelled by the increasing prevalence of chronic diseases. Lifestyle changes and improper weight management contribute to the rise in chronic conditions, with approximately 6 in 10 adults in the USA affected, as reported by the Centers for Disease Control and Prevention. The escalating prevalence of chronic diseases, accounting for $3.8 trillion in annual healthcare costs, is set to boost the immunofluorescence assay market.
Get A Free Sample Of The Global Immunofluorescence Assay Market ReportGlobal Immunofluorescence Assay Market Segments
The global immunofluorescence assay market covered in this report is segmented –
1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence
2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
4) By End User: Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostic Centers
By Geography: The regions covered in the Immunofluorescence Assay market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
Major Immunofluorescence Assay Industry Players
Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., INOVA Diagnostics Inc., Sino Biological Inc., Medipan GmbH, BioLegend Inc., Jackson ImmunoResearch Laboratories Inc., Rockland Immunochemicals Inc., Bethyl Laboratories Inc., Fitzgerald Industries International Inc., Creative Diagnostics, Boster Biological Technology, Acris Antibodies GmbH, RayBiotech Inc., Proteintech Group Inc., Novus Biologicals LLC, R&D Systems Inc., OriGene Technologies Inc., GenScript Biotech Corporation, MBL International Corporation, Abnova Corporation, Cellabs India Technologies Limited, J. Mitra & Co. Pvt. Ltd., EpiGentek Group Inc., Elabscience Biotechnology Co. Ltd., Aesku.Diagnostics GmbH
Get The Full Global Immunofluorescence Assay Market Report
Immunofluorescence Assay Market Overview
The immunofluorescence assay refers to equipment and consumables that operate on a technique, which allows the visualization of specific protein and antigen in infected cells based on their ability to react with specific antibodies by binding a particular antibody chemically conjugated with a fluorescent dye. It is a technique used in the laboratory to diagnose diseases of the skin, kidney, heart, cilia, and other organ systems.
Immunofluorescence Assay Global Market Report 2023 provides data on the global immunofluorescence assay market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The immunofluorescence assay market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.